Form 4 for ANGO ANGIODYNAMICS INC
Accepted 2025-07-22 00:00:00 ET · period of report 2025-07-19 · accession 0001140361-25-026797 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-07-22 | 2025-07-19+ | ANGO | Clemmer James C | Pres, CEO, Dir | F - Tax | $8.76 | -15.3K | 887.5K | -2% | -$134.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-07-20 | F | D | 3,673 | $8.99 | 872,529 | D | — | — | (F4) The exempt disposition of 3,673 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 21, 2021. |
| 2 | Common | Common Stock | 2025-07-20 | F | D | 2,982 | $8.69 | 876,202 | D | — | — | (F3) The exempt disposition of 2,982 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 20, 2022. |
| 3 | Common | Common Stock | 2025-07-19 | F | D | 8,307 | $8.69 | 879,184 | D | — | — | (F2) The exempt disposition of 8,307 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 19, 2023. |
| 4 | Common | Common Stock | 2025-07-19 | F | D | 344 | $8.69 | 887,491 | D | — | — | (F1) The exempt disposition of 344 shares of common stock of AngioDynamics, Inc. ("AngioDynamics") was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 19, 2024. |